Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
15.86
+0.55 (3.59%)
At close: Jun 18, 2025, 4:00 PM
15.81
-0.05 (-0.32%)
After-hours: Jun 18, 2025, 5:41 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.71 billion as of June 18, 2025. Its market cap has decreased by -26.90% in one year.
Market Cap
2.71B
Enterprise Value
2.00B
1-Year Change
-26.90%
Ranking
Category
Stock Price
$15.86
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.71B, an increase of 2,079.57%. That is a compound annual growth rate of 67.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.13B |
| Johnson & Johnson | 373.49B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.14B |
| Abbott Laboratories | 233.12B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |